Quote · The Diary Of A CEO with Steven Bartlett
Leading Cancer Researcher: They’re Ignoring My Research, Cancer Patients Must Know This!
Where this was said
Ghost Mitochondria: Cancer Under the Microscope
At 20:43 · chapter starts 19:59
The electron microscope gave Warburg's intuition its structural proof. Seyfried describes spending over a year going back through the early electron micrograph literature, examining every available image of mitochondria in cancer cells across dozens of cancer types. The verdict was unanimous: all cancer cells show defects in the number, structure, and function of their mitochondria. Many show ghost mitochondria — the outer membrane shell intact, but the cristae (inner membrane folds where energy production happens) missing or grotesquely deformed. [1] — Thomas Seyfried "Under an electron microscope, cancer cells reveal ghost mitochondria — shells with nothing inside, or grotesquely deformed inner structures…" 20:00 Seyfried collaborated with Arismendi Murillo, described as a world leader in cancer electron microscopy, to produce some of the most detailed imagery of this damage. He also notes that the mitochondria-associated membranes — the structures they communicate with inside the cell, including the endoplasmic reticulum — are also abnormal. The foundational biological principle at stake is one every biologist accepts: structure determines function. Damaged structure means damaged function. Seyfried's cutting aside — 'This is known to all biologists except oncologists' — lands with quiet devastation.
Under an electron microscope, cancer cells reveal ghost mitochondria — shells with nothing inside, or grotesquely deformed inner structures. Every cancer cell ever examined shows defects in the number, structure, and function of its mitochondria. Structure determines function: if the organelle is broken, it cannot produce energy properly.
Normal cells generate 34–36 ATP molecules per glucose molecule via oxidative phosphorylation; cancer cells using fermentation produce only 2, making them highly inefficient and fuel-hungry.
Cancer cells cannot burn fat or ketones because their mitochondria are broken. They can only survive on two fuels: glucose (sugar) and glutamine (the most abundant amino acid in the bloodstream). This is why metabolic therapy targets both simultaneously — restrict glucose with ketosis, then target glutamine with repurposed drugs.
